KSA
ALXN

Ken Stern & Associates’s Alexion Pharmaceuticals ALXN Stock Holding History

Ken Stern & Associates’s Portfolio ALXN Stock Details ALXN Fund Activity
Upgrade to unlock
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q3 		$306K Hold
2018
Q2 		$273K Hold
2018
Q1 		$245K Hold
2017
Q4 		$263K Sell
2017
Q3 		$380K Hold
2017
Q2 		$330K Sell
2017
Q1 		$409K Hold
2016
Q4 		$392K Buy